Abstract
BackgroundBone is a common target of metastasis in kidney cancer, and accurately predicting the risk of bone metastases (BMs) facilitates risk stratification and precision medicine in kidney cancer.MethodsPatients diagnosed with kidney cancer were extracted from the Surveillance, Epidemiology, and End Results (SEER) database to comprise the training group from 2010 to 2017, and the validation group was drawn from our academic medical center. Univariate and multivariate logistic regression analyses explored the statistical relationships between the included variables and BM. Statistically significant risk factors were applied to develop a nomogram. Calibration plots, receiver operating characteristic (ROC) curves, probability density functions (PDF), and clinical utility curves (CUC) were used to verify the predictive performance. Kaplan-Meier (KM) curves demonstrated survival differences between two subgroups of kidney cancer with and without BMs. A convenient web calculator was provided for users via “shiny” package.ResultsA total of 43,503 patients were recruited in this study, of which 42,650 were training group cases and 853 validation group cases. The variables included in the nomogram were sex, pathological grade, T-stage, N-stage, sequence number, brain metastases, liver metastasis, pulmonary metastasis, histological type, primary site, and laterality. The calibration plots confirmed good agreement between the prediction model and the actual results. The area under the curve (AUC) values in the training and validation groups were 0.952 (95% CI, 0.950–0.954) and 0.836 (95% CI, 0.809–0.860), respectively. Based on CUC, we recommend a threshold probability of 5% to guide the diagnosis of BMs.ConclusionsThe comprehensive predictive tool consisting of nomogram and web calculator contributes to risk stratification which helped clinicians identify high-risk cases and provide personalized treatment options.
Highlights
Kidney cancer is one of the 10 most oncologic diseases to plague the USA [1, 2]
The variables included in the nomogram were sex, pathological grade, T-stage, N-stage, sequence number, brain metastases, liver metastasis, pulmonary metastasis, histological type, primary site, and laterality
The area under the curve (AUC) values in the training and validation groups were 0.952 and 0.836, respectively
Summary
Kidney cancer is one of the 10 most oncologic diseases to plague the USA [1, 2]. Kidney cancer has historically been considered in general terms as a single disease. RCC is a highly heterogeneous tumor and has an obvious tendency to metastasize distantly Given this feature, 30% of patients will be diagnosed with metastasis even after aggressive treatment of the primary tumor [6]. It has been shown previously that metastatic tumors affect bone turnover differently, and radiographic images of bone metastatic tumors from mRCC are osteolytic or osteoclastic due to an imbalance between osteoclasts and osteoblasts mediated by tumor cells. Osteoclasts often increase their activity because of the upregulation of kappa-B ligand (RANKL) induced by mRCC [7]. Bone is a common target of metastasis in kidney cancer, and accurately predicting the risk of bone metastases (BMs) facilitates risk stratification and precision medicine in kidney cancer
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
